105
Participants
Start Date
July 31, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily
"Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily. The planned dose for the first cohort is 1mg. There will be no more than a 2-fold increase in dose increase in dose between consecutive dose cohorts up to 8 mg, and dose cohorts beyond the 8 mg level will increment no more than 4mg. The maximum dose will not exceed 32mg. The language should precede the text that is currently there"
Wake Research, Raleigh
iResearch Atlanta, LLC, Decatur
Atlanta Center for Medical Research, Atlanta
Palm Springs Research Institute, Hialeah
Louisiana Research Associates, Inc, New Orleans
Woodland International Research Group, Little Rock
IPS Research Company, Oklahoma City
Cutting Edge Research Group, Oklahoma City
Clinical Trials of Texas, Inc. (CTT), San Antonio
Road Runner Research, San Antonio
MCB Clinical Research Centers, LLC, Colorado Springs
Aspen Clinical Research, Orem
Sumitomo Pharma America, Inc.
INDUSTRY